![Sten Gustafsson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Sten Gustafsson is currently the Director-Investor Relations at Irras AB since 2021 and an Analyst at ABG Sundal Collier AB since 2023.
Previously, he worked as an Equity Research Analyst at ABG Sundal Collier AB from 2013 to 2019, an Analyst at ABN AMRO SE, and a Senior Analyst at Nordea Bank ABP (Broker) from 2019 to 2021.
Aktive Positionen von Sten Gustafsson
| Unternehmen | Position | Beginn |
|---|---|---|
| IRRS ABNPV | Investor Relations Kontakt | 09.03.2021 |
ABG Sundal Collier AB
 ABG Sundal Collier AB Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01.08.2023 |
Ehemalige bekannte Positionen von Sten Gustafsson
| Unternehmen | Position | Ende |
|---|---|---|
Nordea Bank ABP (Broker)
 Nordea Bank ABP (Broker) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01.05.2021 |
ABG Sundal Collier AB
ABG Sundal Collier AB Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01.06.2019 |
ABN AMRO SE
 ABN AMRO SE Investment Banks/BrokersFinance Provides security brokerage services | Analyst-Equity | 01.01.2006 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
29
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
ABG Sundal Collier AB
ABG Sundal Collier AB Investment Banks/BrokersFinance Provides brokerage services | Finance |
ABN AMRO SE
ABN AMRO SE Investment Banks/BrokersFinance Provides security brokerage services | Finance |
Nordea Bank ABP (Broker)
Nordea Bank ABP (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Irras AB
 Irras AB BiotechnologyHealth Technology Operates as a commercial-stage medical technology company | Health Technology |
